Prevention of Alzheimer´s Disease Research Grant (worldwide)


The “Prevention Pipeline” from the Alzheimer´s Drug Discovery Foundation provides funding for studies, including clinical trials, that examine whether the use or choice of drugs affects dementia or cognitive decline in three main focus areas:

  • Studies of Cognitive Decline and Risk Reduction
  • Comparative Effectiveness Research
  • Studies Leveraging the Consortium of Cohorts for Alzheimer’s Prevention Action (CAPA)

Funding is available to researchers worldwide, at both non-profit research institutions as well as for-profit organizations. Applicants may apply for up to 5 million USD (direct costs only) for multi-year funding support. There are three assessment rounds per year.

The next letter of intent is due September 29, 2023 and the full application is due on December 1, 2023.

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts


Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.